Quest Diagnostics reports Q2 adjusted EPS $2.30, consensus $2.27

Reports Q2 revenue $2.34B, consensus $2.25B. “We had strong base business performance in the second quarter, with nearly double digit revenue growth year over year,” said Jim Davis, Chairman, CEO and President. “Demand for our services remained strong, boosted by the collaborations we have forged with health plans, hospitals and physicians amid a continued return to care. We are particularly encouraged by revenue growth in our base business of nearly ten percent from our health system customers.”